Biotechnology - Mergers & Acquisitions, North America

Filter

Popular Filters

Actelion bid for Ceptaris looks secured as FDA approves Valchlor

26-08-2013

Privately-held USA-based Ceptaris Therapeutics revealed yesterday (August 26) that the US Food and Drug…

ActelionBiotechnologyCeptaris TherapeuticsDermatologicalsMergers & AcquisitionsNorth AmericaRegulationValchlor

Terms amended in Bellus' acquisition of Thallion

23-07-2013

Canada-based drugmaker Bellus Health (TSX: BLU) has amended its agreement to acquire fellow Canadian…

Antibiotics and Infectious diseasesBellus HealthBiotechnologyMergers & AcquisitionsNorth AmericaShigamabsThallion Pharmaceuticals

Bayer and Onyx file for EU and US approval for expanded use of Nexavar; completes Steigerwald buy

01-07-2013

German drug major Bayer (BAYN: DE) and US partner Onyx Pharmaceuticals (Nasdaq: ONXX) have filed for…

BayerBiotechnologyEuropeMergers & AcquisitionsNexavarNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulationSteigerwald

Biotech industry has "implementation gap" around demonstrating the value of products under development

07-05-2013

Ernst & Young's annual biotech report shows strong performance by major players but a challenging environment…

BiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaResearch

Briefs: Sanofi to up stake in Regeneron; Bayer files for riociguat approval

12-02-2013

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares rise 4.8% to $173.84 in early trading…

BayerBiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegeneronRegulationRespiratory and PulmonaryriociguatSanofi

Tranzyme exploring options, including sale of the firm; is Ache up for sale?

11-02-2013

Following two recent R&D pipeline disappointments, the board of directors of US biotech firm Tranzyme…

Ache Laboratorios FarmaceuticosBiotechnologyMergers & AcquisitionsNorth AmericaPharmaceuticalSouth AmericaTranzyme

FDA approves Protein Sciences egg-free flu vaccine Flublok; and Octapharma's Octaplas

18-01-2013

The US Food and Drug Administration revealed it has approved privately-held US biotech firm Protein Sciences…

Anti-viralsBiotechnologyFlublokMergers & AcquisitionsNorth AmericaOctapharmaOctaplasPanblokPharmaceuticalProtein Sciences CorpRegulationVaccines

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

US FDA clears Amarin's Vascepa, a competitor for Lovaza

30-07-2012

The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with Human Genome?

16-07-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) announced on Friday…

BiotechnologyBreoEuropeGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationRelovairRelvarRespiratory and PulmonaryTheravance

J&J's Janssen files Xarelto with FDA for new indication; buys Chinese firm

03-05-2012

US health care major Johnson & Johnson's (NYSE: JNJ) subsidiary Janssen Research & Development says it…

Asia-PacificBayerBioseal BiotechBiotechnologyCardio-vascularJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationXarelto

Biotech deal-making off to a strong start in 2012, says Burrill

02-02-2012

Swiss drug major Roche's hostile $5.7 billion bid for the tools and sequencing systems company Illumina…

BiotechnologyFinancialLicensingMergers & AcquisitionsNorth America

Biotech predictions for 2012 from sector specialist Steven Burrill

03-01-2012

As 2011 drew to a close, Steven Burrill, chief executive of global life sciences financial services firm…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegulation

US Biotech scores wins in November, despite global economic turmoil, says Burrill

04-12-2011

Economic and political worries in Europe and the USA fuelled another month of wild gyrations in the stock…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaResearch

US biotech sector besieged by debt worries, political dysfunction in 3rd-qtr, says Burrill

06-10-2011

The fight in the USA over the raising of the debt ceiling and the debt crisis in Europe have fueled turmoil…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaRegulation

Company Spotlight

ImmunoGen

ImmunoGen

Back to top